For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive)
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab108383 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Detects a band of approximately 27-34 kDa (predicted molecular weight: 28 kDa).Can be blocked with BDNF peptide (ab199413). Increase dilution if high background is observed|
|IHC||Use at an assay dependent concentration. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.|
|ICC/IF||1/100 - 1/250.|
|IHC-Fr||Use at an assay dependent concentration.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"